Descending Pain Modulation in Fibromyalgia: A Short Review of Mechanisms and Biomarkers
Open Access
- 25 October 2025
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 15 (21) , 2702
Abstract
Fibromyalgia is a prevalent chronic pain disorder characterized by widespread musculoskeletal pain, fatigue, cognitive dysfunction, and sleep disturbances, with high impact in quality of life. Despite extensive research, the pathophysiological mechanisms of fibromyalgia remain partially understood, complicating the diagnosis and treatment. Some evidence underscores the central role of abnormal pain processing, particularly central sensitization and defective descending pain modulation pathways. This review synthesizes and discusses current findings on the neurobiological underpinnings of pain in fibromyalgia, with focus on descending inhibitory control mechanisms and on the role of biomarkers. We integrate data from neurochemical, neuroimaging, and clinical studies to explain how impaired descending modulation contributes to enhanced pain sensitivity and discuss the putative biomarkers associated with changes in descending modulation. A better understanding of descending pain modulation dysfunction in fibromyalgia and related biomarkers is crucial for improving clinical outcomes and developing novel and more effective treatments.Keywords
Funding Information
- Fundação Grünenthal
This publication has 111 references indexed in Scilit:
- Identifying and Managing Nociplastic Pain in Individuals With Rheumatic Diseases: A Narrative ReviewArthritis Care & Research, 2023
- FibromyalgiaJAMA, 2014
- Low‐dose naltrexone for the treatment of fibromyalgia: Findings of a small, randomized, double‐blind, placebo‐controlled, counterbalanced, crossover trial assessing daily pain levelsArthritis & Rheumatism, 2013
- Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensityArthritis & Rheumatism, 2010
- The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom SeverityArthritis Care & Research, 2010
- Elevated insular glutamate in fibromyalgia is associated with experimental painArthritis & Rheumatism, 2009
- Reduced levels of antiinflammatory cytokines in patients with chronic widespread painArthritis & Rheumatism, 2006
- Management of Fibromyalgia SyndromeJAMA, 2004
- Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgiaArthritis & Rheumatism, 2002
- Elevated cerebrospinal fluid levels of substance p in patients with the fibromyalgia syndromeArthritis & Rheumatism, 1994